149 related articles for article (PubMed ID: 20151158)
1. A study on strategies for improving growth and body composition after renal transplantation.
Ferraris JR; Pasqualini T; Alonso G; Legal S; Sorroche P; Galich A; Coccia P; Ghezzi L; Ferraris V; Karabatas L; Guida C; Jasper H
Pediatr Nephrol; 2010 Apr; 25(4):753-62. PubMed ID: 20151158
[TBL] [Abstract][Full Text] [Related]
2. Experience with deflazacort in children and adolescents after renal transplantation.
Schärer K; Feneberg R; Klaus G; Paschen C; Wüster C; Mehls O; Schaefer F
Pediatr Nephrol; 2000 Jun; 14(6):457-63. PubMed ID: 10872183
[TBL] [Abstract][Full Text] [Related]
3. Effects of deflazacort vs. methylprednisone: a randomized study in kidney transplant patients.
Ferraris JR; Pasqualini T; Alonso G; Legal S; Sorroche P; Galich AM; Jasper H;
Pediatr Nephrol; 2007 May; 22(5):734-41. PubMed ID: 17294225
[TBL] [Abstract][Full Text] [Related]
4. Effect of deflazacort versus methylprednisone on growth, body composition, lipid profile, and bone mass after renal transplantation. The Deflazacort Study Group.
Ferraris JR; Pasqualini T; Legal S; Sorroche P; Galich AM; Pennisi P; Domene H; Jasper H
Pediatr Nephrol; 2000 Jul; 14(7):682-8. PubMed ID: 10912543
[TBL] [Abstract][Full Text] [Related]
5. Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot study.
Saviola G; Abdi Ali L; Shams Eddin S; Coppini A; Cavalieri F; Campostrini L; Sacco S; Bucci M; Cirino G; Rossini M
Rheumatology (Oxford); 2007 Jun; 46(6):994-8. PubMed ID: 17384176
[TBL] [Abstract][Full Text] [Related]
6. A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome.
Broyer M; Terzi F; Lehnert A; Gagnadoux MF; Guest G; Niaudet P
Pediatr Nephrol; 1997 Aug; 11(4):418-22. PubMed ID: 9260237
[TBL] [Abstract][Full Text] [Related]
7. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S
Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352
[TBL] [Abstract][Full Text] [Related]
8. Effect of therapy with deflazacort on dyslipoproteinemia after pediatric renal transplantation.
Ferraris JR; Sorroche P; Legal S; Oyhamburu J; Brandi P; Pasqualini T
J Pediatr; 1998 Oct; 133(4):533-6. PubMed ID: 9787693
[TBL] [Abstract][Full Text] [Related]
9. Deflazacort in juvenile chronic arthritis.
Loftus JK; Reeve J; Hesp R; David J; Ansell BM; Woo PM
J Rheumatol Suppl; 1993 Apr; 37():40-2. PubMed ID: 8501751
[TBL] [Abstract][Full Text] [Related]
10. Effects of deflazacort versus prednisone on bone mass, body composition, and lipid profile: a randomized, double blind study in kidney transplant patients.
Lippuner K; Casez JP; Horber FF; Jaeger P
J Clin Endocrinol Metab; 1998 Nov; 83(11):3795-802. PubMed ID: 9814449
[TBL] [Abstract][Full Text] [Related]
11. Effects of deflazacort immunosuppression on long-term growth and growth factors after renal transplantation.
Ferraris JR; Pennisi P; Pasqualini T; Jasper H
Pediatr Nephrol; 1997 Jun; 11(3):322-4. PubMed ID: 9203181
[TBL] [Abstract][Full Text] [Related]
12. The influence of early steroid withdrawal on body composition and bone mineral density in renal transplantation patients.
van den Ham EC; Kooman JP; Christiaans ML; van Hooff JP
Transpl Int; 2003 Feb; 16(2):82-7. PubMed ID: 12595969
[TBL] [Abstract][Full Text] [Related]
13. Effect of therapy with a new glucocorticoid, deflazacort, on linear growth and growth hormone secretion after renal transplantation.
Ferraris JR; Fainstein Day P; Gutman R; Granillo E; Ramirez J; Ruiz S; Pasqualini T
J Pediatr; 1992 Nov; 121(5 Pt 1):809-13. PubMed ID: 1432436
[TBL] [Abstract][Full Text] [Related]
14. The long-term efficacy and safety of two different corticosteroids in chronic sarcoidosis.
Rizzato G; Riboldi A; Imbimbo B; Torresin A; Milani S
Respir Med; 1997 Sep; 91(8):449-60. PubMed ID: 9338047
[TBL] [Abstract][Full Text] [Related]
15. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study.
Lanes R; Gunczler P; Esaa S; Weisinger JR
Clin Endocrinol (Oxf); 2002 Dec; 57(6):725-30. PubMed ID: 12460321
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
Olgaard K; Storm T; van Wowern N; Daugaard H; Egfjord M; Lewin E; Brandi L
Calcif Tissue Int; 1992 Jun; 50(6):490-7. PubMed ID: 1525702
[TBL] [Abstract][Full Text] [Related]
17. Single-center experience in pediatric renal transplantation using thymoglobulin induction and steroid minimization.
Warejko JK; Hmiel SP
Pediatr Transplant; 2014 Dec; 18(8):816-21. PubMed ID: 25311592
[TBL] [Abstract][Full Text] [Related]
18. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
19. Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years.
Höcker B; John U; Plank C; Wühl E; Weber LT; Misselwitz J; Rascher W; Mehls O; Tönshoff B
Transplantation; 2004 Jul; 78(2):228-34. PubMed ID: 15280683
[TBL] [Abstract][Full Text] [Related]
20. Growth and renal function after steroid-free tacrolimus-based immunosuppression in children with renal transplants.
Ellis D
Pediatr Nephrol; 2000 Jul; 14(7):689-94. PubMed ID: 10912544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
